Iovance Biotherapeutics - 53 Year Dividend History | IOVA
Historical dividend payout and yield for Iovance Biotherapeutics (IOVA) since 1971. The current TTM dividend payout for Iovance Biotherapeutics (IOVA) as of November 21, 2024 is $0.00. The current dividend yield for Iovance Biotherapeutics as of November 21, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.511B |
$0.001B |
|
Iovance Biotherapeutics is a clinical-stage pharmaceutical company primarily focused on the development and commercialization of novel T cell-based cancer immunotherapies. These immunotherapies use Generation 2 ('Gen 2') tumor infiltrating lymphocyte (TIL), which harnesses the power of a patient's own immune system to eradicate cancer cells.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
